top of page

Uwe Gottschalk

Uwe Gottschalk is Operating Partner at Keensight Capital - Former CSO of Lonza

Dr. Uwe Gottschalk is Operating Partner at Keensight Capital. formerly CSO of Lonza Group, a Swiss multinational CMO, with major facilities in Europe, North America and Asia. Prior to Lonza, Uwe was Group Vice President of Sartorius AG, and earlier, Head of GMP Purification at Bayer
Health Care.Chief Scientific Officer

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
MEETINGS
MEMBERS
Speakers
Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jesse McCool

CSO of Bionova Scientific

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Thomas Potgieter

Senior Vice President, Cell Therapy Development and Operations

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt, PhD MBA

Director Global Cell & Gene Therapies Portfolio Management at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Paolo Martini

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Gwendolyn Binder PhD

President, Science and Technology at Cabaletta Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Warner Biddle

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jens Vogel

SVP & Head of Global Biologics Operating Unit, Merck & Co

bottom of page